TrueBlue (TBI) PT Raised to $7 at BMO Capital
Tweet
Share
E-mailGet Alerts TBI Hot Sheet
Price: $10.66 +2.01%
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 19
Rating Summary:
3 Buy, 4 Hold, 0 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 13 | Down: 11 | New: 19
Join SI Premium – FREE
BMO Capital analyst Jeffrey Silber raised the price target on TrueBlue (NYSE: TBI) to $7.00 (from $6.00) while maintaining a Outperform rating.
You May Also Be Interested In
- TrueBlue’s PeopleScout Named a Leader in Everest Group's RPO PEAK Matrix® Assessment 2026
- VTEX (VTEX) PT Lowered to $5.10 at Jefferies
- Lucky Strike Entertainment (LUCK) PT Lowered to $10 at Oppenheimer
Create E-mail Alert Related Categories
Analyst PT ChangeSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
